Data / Form D filings / Curza, Inc.
Curza, Inc.: Form D filing
Curza, Inc., a pharmaceuticals company in Salt Lake City, UT, filed a Form D with the SEC in 2023. The latest, on June 7, 2023, reports $367,233 sold of a $1.8 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 650 KOMAS DR, STE 202, Salt Lake City, UT, 84108
- Phone
- (801) 680-2363
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1978799
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 7, 2023 | New notice | $1,750,000 | $367,233 | $1,382,767 | 11 | May 25, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Flagg Armstrong | Director | |
| John Kozarich | Director | |
| Joseph Flagg Sorenson | Director | |
| Lloyd Flagg Czaplewiski | Director | |
| J. Flagg Flanagan | Director | |
| Richard Flagg McKoewn | Director | |
| Charles Testa | Executive Officer, Director |
Every Form D from the week of Jun 5, 2023 · All recent filings in Utah · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Curza, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.